CagriSema
Ask about this stack
Get a grounded answer across clinical evidence, community patterns, and risks.
55
authors mention this stack
21
ran the components concurrently
CagriSema (Cagrilintide + Semaglutide) appears in 55 author journeys (21 as actual concurrent use). Common goals: weight loss; Weight loss and appetite suppression; Weight loss. Typical doses reported: Cagrilintide 1mg, Semaglutide 2.4mg. Reported side effects include: Increased resting heart rate, constipation, headache
Typical doses reported
Cagrilintide 1mg
Semaglutide 2.4mg
Community-reported doses are not medical guidance.
How people are running it
24
Recommended / discussed
15
Currently running
11
Planning to run
7
Ran in the past
1
Unclear
What people use it for
weight lossWeight loss and appetite suppressionWeight losslong term weight maintenanceTo clear out the freezer stash of unused peptides, experiment during maintenance, and act as a backup protocol if Tirzepatide loses its effectiveness.Hunger suppression / weight loss
Sample reported outcomes
- ✓ Weight loss down to 139 lbs
- ✓ Successfully maintaining weight at 138-145 lbs (total loss of 110 lbs)
- ✓ Broke stalls, reached goal weight, lost 105 lbs total, eliminated food noise
- ✓ Discussed the chemical instability of combining Cagrilintide and Semaglutide into a single formulation
- ✓ down 40lbs so far
- ✓ Decided not to go through with it after research and community feedback
- ✓ Unsuccessful; did not break the stall and caused severe gastrointestinal distress
- ✓ Highly effective suppression of hunger and food noise for 4 days post-Wednesday dose, increased rate of weight loss, and significant relief from chronic joint and body pain/inflammation
Self-reported community experiences, not verified results.
Sample reported side effects
- ⚠ Increased resting heart rate, constipation, headache
- ⚠ Constipation (managed with Miralax), Cagrilintide warms the author up while Tirzepatide/Semaglutide keep them cold, dry mouth, no fatigue, high energy
- ⚠ Constipation, warmth and energy (from Cagrilintide/Tesofensine), coldness (from Tirzepatide/Semaglutide)
- ⚠ None
- ⚠ Severe constipation ('pooping bricks') that almost resulted in an ER visit and required several enemas to resolve
- ⚠ Very slight, transient nausea the day after Semaglutide and Cagrilintide administration
- ⚠ Slight diarrhea and flatulence on the first day, which the author suspected was due to the Cagrilintide component.
- ⚠ Not stated